Orthopedic Surgery · Gonzales, LA
NPI
1700802733
Since 2006
Specialty
Orthopedic Surgery
Code 207X00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1014 W Saint Clare Blvd, Suite 1020
Gonzales, LA, 70737
Phone (225) 743-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$106K
2,060 services
Medicare patients, 2024
193
Average age 71
Drug cost, 2024
$1.0M
14,220 prescriptions
Company payments, 2025
$1,361
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott G Petrie was code 99214 (office e&m - established), 954 times for 180 patients. In total Scott G Petrie billed 2,060 services in 54 codes, and Medicare paid $106K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-08-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 954 | 180 | $75.52 | $72K |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 528 | 91 | $5.22 | $2,759 |
| 73560 X-ray - Lower Extremity | Office | 100 | 41 | $20.42 | $2,042 |
| 20553 Musculoskeletal | Office | 87 | 49 | $36.74 | $3,197 |
| 20610 Joint Injection | Office | 76 | 44 | $40.69 | $3,092 |
| 99204 Office E&M - New | Office | 37 | 37 | $101.15 | $3,743 |
| 99213 Office E&M - Established | Office | 27 | 20 | $60.84 | $1,643 |
| 72110 X-ray - Spine and Pelvis | Office | 27 | 25 | $33.38 | $901 |
| 20550 Musculoskeletal | Office | 25 | 21 | $32.47 | $812 |
| 73130 X-ray - Upper Extremity | Office | 23 | 14 | $22.88 | $526 |
| 73030 X-ray - Upper Extremity | Office | 20 | 17 | $21.38 | $428 |
| 64450 Musculoskeletal | Facility | 12 | 11 | $14.21 | $171 |
By year: 2022 $162K for 4,139 services; 2023 $129K for 2,299 services; 2024 $106K for 2,060 services.
Medicare prescription drug claims, 2024
In 2024, the drug Scott G Petrie prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 2,292 prescriptions and refills. In total Scott G Petrie wrote 14,220 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 2,292 | 2,293 | 283 | $552K |
| Celecoxib Generic | 1,926 | 2,522 | 514 | $45K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,724 | 1,725 | 296 | $26K |
| Gabapentin Generic | 1,539 | 1,895 | 272 | $13K |
| Pregabalin Generic | 1,440 | 1,585 | 380 | $16K |
| Tramadol Hcl Generic | 1,097 | 1,098 | 155 | $5,510 |
| Cyclobenzaprine Hcl Generic | 915 | 1,049 | 175 | $5,425 |
| Meloxicam Generic | 643 | 751 | 118 | $1,795 |
| Baclofen Generic | 613 | 725 | 139 | $3,529 |
| Tizanidine Hcl Generic | 526 | 626 | 79 | $3,378 |
| Methocarbamol Generic | 196 | 220 | 44 | $9,320 |
| Diclofenac Sodium Generic | 180 | 209 | 62 | $6,820 |
| Lidocaine Generic | 116 | 138 | 21 | $9,060 |
| Ondansetron Odt Ondansetron | 112 | 147 | 29 | $1,654 |
| Movantik Naloxegol Oxalate | 74 | 74 | 32 | $25K |
Brand drugs: 258 claims; generic drugs: 13,962 claims; opioid claims: 5,172.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott G Petrie $1,361 ($1,361 in general payments such as food, travel and fees) from 12 companies. The largest payer was Forte Bio-Pharma LLC with $339.
| Company | Payments | Amount |
|---|---|---|
| Forte Bio-Pharma LLC | 18 | $339 |
| Amgen Inc. AMGN | 9 | $239 |
| Radius Health, Inc. | 7 | $199 |
| Zynex Medical, Inc. | 1 | $169 |
| Stryker Corporation SYK | 3 | $91.92 |
| Valinor Pharma, LLC | 4 | $74.71 |
| Vertex Pharmaceuticals Incorporated VRTX | 4 | $67.29 |
| Virtus Pharmaceuticals LLC | 2 | $50.05 |
| Dynasplint Systems Inc. | 1 | $45.93 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $37.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.